COSM
Cosmos Health Inc.
$0.2130
-11.98%
$13.2M
No data for this timeframe.
Vol
Market Cap$13.2M
Cap SizeNano Cap
Inst. Holders15 funds
Inst. Value$413.8K
Inst. Activity1 buys / 0 sells
Reddit Sentiment56° Neutral
SEC Reports6
Press Releases9
Exchange Nasdaq·Sector Wholesale-Drugs, Proprietaries & Druggists' Sundries·Inc. NV·CIK 0001474167·Prev Close $0.2420
Recent Activity
Jun 12, 2026
SEC
Cosmos Health announced strong sales momentum for its proprietary antiseptic brands C-Scrub and C-Sept, with over $1.5 m
PRESS-RELEASE — Impact 4/10
Jun 8, 2026
SEC
Cosmos Health filed Amendment No. 1 to its S-3 shelf registration statement, primarily responding to SEC comments on ris
S-3/A — Impact 7/10
Jun 5, 2026
SEC
Cosmos Health filed a DEFA14A to correct a clerical error in the sample proxy card included with its June 2, 2026 defini
DEFA14A — Impact 2/10
Inst.
HRT FINANCIAL LP — DOUBLED
67,280 shares ($21.00)
Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
334,575 shares ($166.6K)
Jun 18, 2026
earnings
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity
CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NA
Jun 17, 2026
Press
Cosmos Health, through its subsidiary Cana Laboratories, signed a five-year contract manufacturing agreement with Pharme
Impact 4/10
Jun 12, 2026
Press
Cosmos Health's subsidiary Cana Laboratories received new contract manufacturing orders from Nassington and Verisfield f
Impact 3/10
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$4.50
Current $0.2129
Low $4.50
Median $4.50
High $4.50
1 analysts
$4.50
$4.50
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.01 ▲ +104.2% | $0.01 — $0.01 | 1 | |
| Next Q | $0.02 | $0.02 — $0.02 | 112% YoY | 1 |
| Current FY | $0.01 ▼ -87.5% | $0.01 — $0.01 | 102% YoY | 1 |
| Next FY | $0.07 | $0.07 — $0.07 | 600% YoY | 1 |
Latest Reports
BULLISH
Press
4/10
Cosmos Health, through its subsidiary Cana Laboratories, signed a five-year contract manufacturing agreement with Pharme
Jun 17, 2026
NEUTRAL
PRESS-RELEASE
4/10
Cosmos Health announced strong sales momentum for its proprietary antiseptic brands C-Scrub and C-Sept, with over $1.5 m
Jun 12, 2026
BEARISH
S-3/A
7/10
Cosmos Health filed Amendment No. 1 to its S-3 shelf registration statement, primarily responding to SEC comments on ris
Jun 8, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| FMR LLC | — | — |
| RENAISSANCE TECHNOLOGIES LLC | $123.9K | DOUBLED |
| CITADEL ADVISORS LLC | $94.0K | DOUBLED |
| BlackRock, Inc. | $84.9K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $44.4K | — |
Reddit Sentiment
56°
Neutral
Bearish
Neutral
Bullish
15 institutional holders with $413.8K total value (1,371,903 shares) as of 2026-Q1. Top holders: FMR, RENAISSANCE, CITADEL. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | FMR LLC | — | $0.00 | 0.0% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 390,500 | $123.9K | 29.9% | DOUBLED +260.5% |
| 3 | CITADEL ADVISORS LLC | 296,300 | $94.0K | 22.7% | DOUBLED +133.1% |
| 4 | BlackRock, Inc. | 267,797 | $84.9K | 20.5% | — |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 140,007 | $44.4K | 10.7% | — |
| 6 | VANGUARD FIDUCIARY TRUST CO | 95,735 | $30.3K | 7.3% | — |
| 7 | STATE STREET CORP | 45,243 | $14.4K | 3.5% | ADD +82.9% |
| 8 | CITADEL ADVISORS LLC | 40,306 | $12.8K | 3.1% | DOUBLED +133.1% |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 17,734 | $5.6K | 1.4% | — |
| 10 | NATIONAL BANK OF CANADA /FI/ | 6,357 | $2.0K | 0.5% | — |
| 11 | GROUP ONE TRADING LLC | 2,373 | $753.00 | 0.2% | TRIM -44.2% |
| 12 | Allworth Financial LP | 1,241 | $394.00 | 0.1% | — |
| 13 | CITIGROUP INC | 990 | $314.00 | 0.1% | — |
| 14 | HRT FINANCIAL LP | 67,280 | $21.00 | 0.0% | DOUBLED +162.2% |
| 15 | WELLS FARGO & COMPANY/MN | 40 | $13.00 | 0.0% | DOUBLED +900.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | DOUBLED | 25,661 | 67,280 | +162.2% | $21.00 | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 92,800 | 334,575 | +260.5% | $166.6K | 2025-Q4 |
| STATE STREET CORP | ADD | 24,743 | 45,243 | +82.9% | $22.5K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 4 | 40 | +900.0% | $20.00 | 2025-Q4 |
| HRT FINANCIAL LP | DOUBLED | 10,567 | 25,661 | +142.8% | $12.00 | 2025-Q4 |
| VANGUARD GROUP INC | ADD | 134,834 | 235,742 | +74.8% | $261.7K | 2025-Q3 |
| CITADEL ADVISORS LLC | DOUBLED | 96,731 | 225,507 | +133.1% | $250.3K | 2025-Q3 |
| GROUP ONE TRADING LLC | TRIM | 4,284 | 2,392 | -44.2% | $2.7K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 62,377 | 216 | -99.7% | $240.00 | 2025-Q3 |
| UBS Group AG | TRIM | 115,667 | 71,516 | -38.2% | $47.8K | 2024-Q4 |
| GROUP ONE TRADING LLC | ADD | 1,526 | 2,884 | +89.0% | $1.9K | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 131 | 173 | +32.1% | $116.00 | 2024-Q4 |
| GROUP ONE TRADING LLC | NEAR_EXIT | 9,881 | 1,526 | -84.6% | $1.3K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 2 mixed, 2 neutral. Avg impact: 5.2/10.
NEUTRAL
PRESS-RELEASE
4/10
Cosmos Health announced strong sales momentum for its proprietary antiseptic brands C-Scrub and C-Se
Jun 12, 2026
BEARISH
S-3/A
7/10
Cosmos Health filed Amendment No. 1 to its S-3 shelf registration statement, primarily responding to
Jun 8, 2026
NEUTRAL
DEFA14A
2/10
Cosmos Health filed a DEFA14A to correct a clerical error in the sample proxy card included with its
Jun 5, 2026
MIXED
8-K
5/10
Cosmos Health reported Q1 2026 revenue of $17.93M, up 30.7% YoY, a new Q1 record, but GAAP net loss
May 22, 2026
BEARISH
S-3/A
7/10
Cosmos Health is registering 73.5 million shares for resale by two selling stockholders, ATW and M2B
Apr 24, 2026
MIXED
8-K
6/10
Cosmos Health reported full-year 2025 results with record revenue of $65.27M (up 20% YoY) and gross
Apr 16, 2026
BULLISH
4/10
Cosmos Health, through its subsidiary Cana Laboratories, signed a five-year contract manufacturing a
Jun 17, 2026
NEUTRAL
3/10
Cosmos Health's subsidiary Cana Laboratories received new contract manufacturing orders from Nassing
Jun 12, 2026
BULLISH
5/10
Cosmos Health's subsidiary Cana Labs signed a three-year contract manufacturing deal with Verisfield
Jun 10, 2026
NEUTRAL
4/10
Cosmos Health subsidiary Cana Laboratories inaugurated a new capsule production line and secured a f
Jun 9, 2026
NEUTRAL
3/10
Cosmos Health's subsidiary Cana Laboratories acquired international patent application WO2025108566A
Jun 8, 2026
NEUTRAL
3/10
Cosmos Health announced the planned launch of its C-Scrub antimicrobial wash in a veterinary formula
Jun 1, 2026
NEUTRAL
4/10
Cosmos Health issued a multi-year financial guidance press release projecting revenue growth from $6
May 26, 2026
MIXED
6/10
Cosmos Health provided a corporate update highlighting record revenue, a U.S. expansion with its NOO
Mar 19, 2026
NEUTRAL
4/10
Cosmos Health Inc. (COSM) announced the purchase of $600,000 in Bitcoin, increasing its total digita
Mar 11, 2026
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$4.50 mean target
$4.50 Low
$4.50 High
| Metric | Value |
|---|---|
| Current Price | $0.2129 |
| Target Low | $4.50 |
| Target Mean | $4.50 |
| Target Median | $4.50 |
| Target High | $4.50 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.01 | $0.01 | $0.01 | — | +104.2% | 1↑ 0↓ | $0.0B | — | 1 |
| Next Q 2026-09-30 |
$0.02 | $0.02 | $0.02 | 111.8% | +0.0% | 1↑ 0↓ | $0.0B | — | 1 |
| Current FY 2026-12-31 |
$0.01 | $0.01 | $0.01 | 101.6% | -87.5% | 0↑ 1↓ | $0.1B | 33.8% | 1 |
| Next FY 2027-12-31 |
$0.07 | $0.07 | $0.07 | 600.0% | +0.0% | — | $0.1B | 26.9% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.010 | |
| 7d ago | $0.010 | |
| 30d ago | $-0.240 | +0.250 |
| 60d ago | $-0.030 | +0.040 |
| 90d ago | $-0.030 | +0.040 |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
56°
Neutral
Bearish
Neutral
Bullish
5 mentions
3 bullish
2 bearish
5 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 15, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Jun 15, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Jun 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 13, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 5, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Looking strongly at COSM
▲ 1
💬 1
⚡ 0.5
Roast my stock picks and tell me if you'd invest.
▲ 1
💬 1
⚡ 0.5
Jun 18, 2026
earnings
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity
CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated
Jun 18, 2026
short_volume
Short Volume: COSM — 60.4% short (5.4M / 9.0M)
Short: 5,421,029 | Exempt: 893,815 | TRF Vol: 8,971,009 | Short Ratio: 60.4% | Off-exchange volume (dark pool + OTC)
Jun 17, 2026
other
Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States
Cosmos Health enters the global skincare market. Sales already underway in the United States.
Jun 17, 2026
contract
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
Cosmos Health signs 1.72 million-unit contract manufacturing agreement With Pharmex S.A. across three dermatological products.
Jun 15, 2026
short_volume
Short Volume: COSM — 55.9% short (17.7M / 31.7M)
Short: 17,749,555 | Exempt: 624,457 | TRF Vol: 31,733,702 | Short Ratio: 55.9% | Off-exchange volume (dark pool + OTC)
Jun 12, 2026
contract
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
Jun 12, 2026
earnings
Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit
Cosmos Health announces strong sales momentum for its proprietary antiseptic brands, C-Scrub and C-Sept.
Jun 12, 2026
short_volume
Short Volume: COSM — 59.6% short (2.0M / 3.3M)
Short: 1,956,885 | Exempt: 345,062 | TRF Vol: 3,283,182 | Short Ratio: 59.6% | Off-exchange volume (dark pool + OTC)
Jun 11, 2026
m_and_a
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
Cosmos Health signs LOI to acquire Doc Pharma S.A.
Jun 11, 2026
activist
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
Cosmos Health secures additional 180-day Nasdaq extension to regain compliance.
Jun 11, 2026
short_volume
Short Volume: COSM — 55.8% short (1.4M / 2.4M)
Short: 1,355,496 | Exempt: 362,362 | TRF Vol: 2,429,878 | Short Ratio: 55.8% | Off-exchange volume (dark pool + OTC)
Jun 10, 2026
contract
Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries
Cosmos Health secures a 3-year contract manufacturing agreement for 3.9 million units of VASCLOR GEST progesterone pessaries.
Jun 10, 2026
short_volume
Short Volume: COSM — 60.0% short (2.5M / 4.1M)
Short: 2,479,853 | Exempt: 827,490 | TRF Vol: 4,135,292 | Short Ratio: 60.0% | Off-exchange volume (dark pool + OTC)
Jun 9, 2026
contract
Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN
Cosmos Health inaugurates state-of-the-art capsule production line and secures new 5-year contract manufacturing agreement for 385,000 units
Jun 9, 2026
short_volume
Short Volume: COSM — 57.5% short (2.1M / 3.7M)
Short: 2,122,276 | Exempt: 536,358 | TRF Vol: 3,693,852 | Short Ratio: 57.5% | Off-exchange volume (dark pool + OTC)